A Replication Study of the IRS1, CAPN10, TCF7L2, and PPARG Gene Polymorphisms Associated with Type 2 Diabetes in Two Different Populations of Mexico

Annals of Human Genetics

Volumn 75, Issue 5, 2011, Pages 612-620

  Martínez Gómez, Laura E ^a   Cruz, Miguel ^b   Martínez Nava, Gabriela A ^a   Madrid Marina, Vicente ^a   Parra, Esteban ^c   García Mena, Jaime ^d   Espinoza Rojo, Mónica ^e   Estrada Velasco, Barbara I ^a   Piza Roman, Luis F ^f   Aguilera, Penelope ^g   Burguete García, Ana I ^a  

^a INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^b HOSPITAL DE ESPECIALIDADES   (Mexico)

^c UNIVERSITY OF TORONTO   (Canada)

^d DEPARTAMENTO DE FÍSICA   (Mexico)

^e UNIVERSIDAD AUTÓNOMA DE GUERRERO   (Mexico)

^f Hospital General de Zona No4 Iguala   (Mexico)

^g NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

Author keywords

Candidate genes; Mexican population; Type 2 diabetes

Indexed keywords

CALPAIN 10; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN RECEPTOR SUBSTRATE 1; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRANSCRIPTION FACTOR 7 LIKE 2; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GENDER; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GLUCOSE BLOOD LEVEL; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEXICO; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REPLICATION STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; CALPAIN; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INSULIN RECEPTOR SUBSTRATE PROTEINS; MALE; MEXICO; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PPAR GAMMA; TRANSCRIPTION FACTOR 7-LIKE 2 PROTEIN;

EID: 80051557835     PISSN: 00034800     EISSN: 14691809     Source Type: Journal    
DOI: 10.1111/j.1469-1809.2011.00668.x     Document Type: Article

References (35)

1. Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl MC, Nemesh J, Lane CR, Schaffner SF, Bolk S, Brewer C, Tuomi T, Gaudet D, Hudson TJ, Daly M, Groop L, Lander ES. (2000) The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 26, 76-80.
2. Black MH, Fingerlin TE, Allayee H, Zhang W, Xiang AH, Trigo E, Hartiala J, Lehtinen AB, Haffner SM, Bergman RN, McEachin RC, Kjos SL, Lawrence JM, Buchanan TA, Watanabe RM (2008) Evidence of interaction between PPARG2 and HNF4A contributing to variation in insulin sensitivity in Mexican Americans. Diabetes 57, 1048-1056.
3. Burguete-Garcia AI, Cruz-Lopez M, Madrid-Marina V, Lopez-Ridaura R, Hernández-Avila M, Cortina B, Gómez RE, Velasco-Mondragón E (2010) E. Association of Gly972Arg polymorphism of IRS-1 gene with type 2 diabetes mellitus in lean participants of a national health survey in Mexico: a candidate gene study. Metabolism. 59, 38-45.
4. Chandak GR, Janipalli CS, Bhaskar S, Kulkarni SR, Mohankrishna P, Hattersley AT, Frayling TM, Yajnik CS (2007) Common variants in the TCF7L2 gene are strogly associated with type 2 diabetes mellitus in the Indian population. Diabetologia. 50, 63-67.
5. Cruz M, García-Mena J, López-Orduña E, Valladares A, Sánchez R, Wacher-Rodarte N, Aguilar-Gaytán R y Kumate J (2005) Genes candidatos como posibles marcadores de susceptibilidad a Diabetes tipo 2. REB. 24, 81-86.
6. Cruz M, Valladares-Salgado A, Garcia-Mena J, Ross K, Edwards M, Angeles-Martinez J, Ortega-Camarillo C, de la Peña JE, Burguete-Garcia AI, Wacher-Rodarte N, Ambriz R, Rivera R, D'artote AL, Peralta J, Parra EJ, Kumate J (2010) Candidate gene association study conditioning on individual ancestry in type 2 diabetes and metabolic síndrome patients from Mexico City. Diabetes Metab Res Rev. 26, 261-270.
7. Damcott CM, Pollin TI, Reinhart LJ, Ott SH, Shen H, Silver KD, Mitchell BD, Shuldiner AR (2006) Polymorphisms in the Transcription Factor 7-Like 2 (TCF7L2) Gene are Associated with Type 2 Diabetes in the Amish: replication and evidence for a role in both insulin secretion and insulin resistance. Diabetes. 55, 2654-2659.
8. Das SK, Elbein S. (2006) The genetic basis of Type 2 Diabetes. Cellscience. 4, 100-131.
9. del Bosque-Plata L, Aguilar-Salinas CA, Tusié-Luna MT, Ramírez-Jiménez S, Rodríguez-Torres M, Aurón-Gómez M, Ramírez E, Velasco-Pérez ML, Ramírez-Silva A, Gómez-Pérez F, Hanis CL, Tsuchiya T, Yoshiuchi I, Cox NJ, Bell GI (2004) Association of the calpain-10 gene with type 2 diabetes mellitus in a Mexican population. Mol Genet Metab. 81, 122-126.
10. Florez JC, Jablonski KA, Bayley N, Pollin TI, de Bakker PI, Shuldiner AR, Knowler WC, Nathan DM, Altshuler D; Diabetes Prevention Program Research Group (2006) TCF7L2 polymorphisms and progression to diabetes in the diabetes prevention program. N Engl J Med. 355, 241-50.
11. Garant MJ, Kao WH, Brancati F, Coresh J, Rami TM, Hanis CL, Boerwinkle E, Shuldiner AR; Atherosclerosis Risk in Communities Study (2002) SNP43 of CAPN10 and the risk of type 2 diabetes in African-Americans. The Atherosclerosis Risk in Communities Study. Diabetes. 51, 231-7.
12. Ghoussaini M, Meyre D, Lobbens S, Charpentier G, Clément K, Charles MA, Tauber M, Weill J, Froguel P (2005) Implication of the Pro12Ala polymorphism of the PPAR-gamma 2 gene in type 2 diabetes and obesity in the French population. BMC Med Genet. 22, 6-11.
13. Gouda HN, Sagoo GS, Harding AH, Yates J, Sandhu MS, Higgins JP (2010) The association between the peroxisome proliferator-activated receptor-g2 (PPARG2) Pro12Ala gene variant and Type 2 diabetes mellitus: a HuGE review and meta-analysis. Am J Epidemiol. 171, 645-655.
14. Grant SF, Thorleifsson G, Reynisdottir I, Benediktsson R, Manolescu A, Sainz J, Helgason A, Stefansson H, Emilsson V, Helgadottir A, Styrkarsdottir U, Magnusson KP, Walters GB, Palsdottir E, Jonsdottir T, Gudmundsdottir T, Gylfason A, Saemundsdottir J, Wilensky RL, Reilly MP, Rader DJ, Bagger Y, Christiansen C, Gudnason V, Sigurdsson G, Thorsteinsdottir U, Gulcher JR, Kong A, Stefansson K. (2006) Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet. 38, 320-323
15. Gupta V, Khadgawat R, Ng HK, Kumar S, Aggarwal A, Rao VR, Sachdeva MP. (2010) A validation study of type 2 diabetes-related variants of the TCF7L2, HHEX, KCNJ11, and ADIPOQ genes in one endogamous ethnic group of north India. Ann Hum Genet. 74, 361-368.
16. Heikkinen S, Auwerx J, Argmann CA. (2007) PPARG in human and mouse physiology. Biochim Biophys Acta. 1771, 999-1013.
17. Hoggart CJ, Parra EJ, Shriver MD, Bonilla C, Kittles RA, Clayton DG, McKeigue PM (2003) Control of confounding of genetic associations in stratified populations. Am J Hum Genet. 72, 1492-1504.
18. Horikawa Y, Oda N, Cox NJ, Li X, Orho-Melander M, Hara M, Hinokio Y, Lindner TH, Mashima H, Schwarz PE, del Bosque-Plata L, Horikawa Y, Oda Y, Yoshiuchi I, Colilla S, Polonsky KS, Wei S, Concannon P, Iwasaki N, Schulze J, Baier LJ, Bogardus C, Groop L, Boerwinkle E, Hanis CL, Bell GI. (2000) Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet. 26, 163-175.
19. Jellema A, Zeegers MP, Feskens EJ, Dagnelie PC, Mensink RP (2003) Gly972Arg variant in the insulin receptor substrate-1 gene and association with Type 2 diabetes: a meta-analysis of 27 studies. Diabetologia. 46, 990-995.
20. Krook A, Wallberg-Henriksson H, Zierath JR (2004) Sending the signal: Molecular mechanisms regulating glucose uptake. Med. Sci. Sports Exerc. 36, 1212-1217.
21. Lyssenko V, Lupi R, Marchetti P, Del Guerra S, Orho-Melander M, Almgren P, Sjögren M, Ling C, Eriksson KF, Lethagen AL, Mancarella R, Berglund G, Tuomi T, Nilsson P, Del Prato S, Groop L (2007) Mechanisms by wich common variants in the TCF7L2 gene increase risk of type diabetes. J Clin Invest. 117, 2155-2163.
22. Mao X, Bigham AW, Mei R, Gutierrez G, Weiss KM, Brutsaert TD, Leon-Velarde F, Moore LG, Vargas E, McKeigue PM, Shriver MD, Parra EJ (2007) A genomewide admixture mapping panel for Hispanic/Latino populations. Am J Hum Genet. 80, 1171-1178.
23. Martinez-Marignac VL, Valladares A, Cameron E, Chan A, Perera A, Globus-Goldberg R, Wacher N, Kumate J, McKeigue P, O'Donnell D, Shriver MD, Cruz M, Parra EJ (2007) Admixture in Mexico City: implications for admixture mapping of type 2 diabetes genetic risk factors. Hum Genet. 120, 807-819.
24. Olaiz-Fernández G, Rivera-Dommarco J, Shamah-Levy T, Rojas R, Villalpando-Hernández S, Hernández-Avila M, Sepúlveda-Amor J. Encuesta Nacional de Salud y Nutrición (2006). Cuernavaca, México: Instituto Nacional de Salud. ISBN 970-9874-20-29
25. Olaiz-Fernández Gustavo, Rojas Rosalba, Aguilar-Salinas Carlos A, Rauda Juan, Villalpando Salvador. (2007) Diabetes mellitus en adultos mexicanos: resultados de la Encuesta Nacional de Salud 2000. Salud pública Méx. 49, S331-S337.
26. Orho-Melander M, Klannemark M, Svensson MK, Ridderstråle M, Lindgren CM, Groop L. (2002) Variants in the calpain-10 gene predispose to insulin resistance and elevated free fatty acid levels. Diabetes. 51, 2658-2664.
27. Palmer ND, Lehtinen AB, Langefeld CD, Campbell JK, Haffner SM, Norris JM, Bergman RN, Goodarzi MO, Rotter JI, Bowden DW (2008) Association of TCF7L2 gene polymorphisms with reduced acute insulin response in Hispanic Americans. J Clin Endocrinol Metab. 93, 304-309.
28. Parra EJ, Cameron E, Simmonds L, Valladares A, McKeigue P, Shriver M, Wacher N, Kumate J, Kittles R, Cruz M (2007) Association of TCF7L2 polymorphisms with type 2 diabetes in Mexico City. Clin Genet. 71, 359-366.
29. Sáez ME, González-Sánchez JL, Ramírez-Lorca R, Martínez-Larrad MT, Zabena C, González A, Morón FJ, Ruiz A, Serrano-Ríos M (2008) The CAPN10 gene is associated with insulin resistance phenotypes in the Spanish population. Plos One. 13, e2953, doi:.
30. Sesti G, Federici M, Hribal ML, Lauro D, Sbraccia P, Lauro R (2001) Defects of the insulin receptor substrate (IRS) system in human metabolic disorders. FASEB Journals. 15, 2099-2111.
31. Sladek R, Rocheleau G, Rung J, Dina C, Shen L, Serre D, Boutin P, Vincent D, Belisle A, Hadjadj S, Balkau B, Heude B, Charpentier G, Hudson TJ, Montpetit A, Pshezhetsky AV, Prentki M, Posner BI, Balding DJ, Meyre D, Polychronakos C, Froguel P. (2007) A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445, 881-885.
32. Tian C, Hinds DA, Shigeta R, Adler SG, Lee A, Pahl MV, Silva G, Belmont JW, Hanson RL, Knowler WC, Gregersen PK, Ballinger DG, Seldin MF. (2007) A genomewide single-nucleotide-polymorphism panel for Mexican American Admixture Mapping. Am J Hum Genet. 80, 1014-1023.
33. Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N. (2004) Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst. 96, 434-442.
34. Weedon MN, McCarthy MI, Hitman G, Walker M, Groves CJ, Zeggini E, Rayner NW, Shields B, Owen KR, Hattersley AT, Frayling TM. (2006) Combining information from common type 2 diabetes risk polymorphisms improves disease prediction. PLoS Med. 10, e374, doi:.
35. White M. (2002) IRS proteins and the common path to diabetes. Am J Physiol Endocrinol Metab. 283, E413-E422.